Evidence map›Paper›PMID 21565205›Full record

ArticleLife sciences2011

Important role of neutrophils in the late asthmatic response in mice.

Takeshi Nabe, Fusa Hosokawa, Kouki Matsuya, Toyoko Morishita, Ayumu Ikedo, Masanori Fujii, Nobuaki Mizutani, Shin Yoshino, David D Chaplin

Abstract read
In one paragraph

Article in Life sciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. TThe Journal of allergy and clinical immunology · 2022
    Article
  3. Review
  4. Intranasal administration ofExperimental and therapeutic medicine · 2019
    Article
  5. Article
  6. Article
  7. Article
  8. Sputum neutrophil count after bronchial allergen challenge is related to peripheral blood neutrophil chemotaxis in asthma patients.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2014
    Article
  9. Key mediators in the immunopathogenesis of allergic asthma.International immunopharmacology · 2014
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Microbes and asthma: the missing cellular and molecular links.Current opinion in pulmonary medicine · 2012
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Takeshi NabeDepartment of Pharmacology, Kyoto Pharmaceutical University, Kyoto 607-8414, Japan. nabe@mb.kyoto-phu.ac.jp
Fusa Hosokawa
Kouki Matsuya
Toyoko Morishita
Ayumu Ikedo
Masanori Fujii
Nobuaki Mizutani
Shin Yoshino
David D Chaplin
Kyoto Pharmaceutical University · JPKobe Pharmaceutical University · JPUniversity of Alabama at Birmingham · US

Funding

The Effect of Mycoplasma on Chronic AsthmaP01HL073907 · NHLBI · NATIONAL JEWISH HEALTH · PI CHU, HONG W · 2004 to 2008
$10.3M
NHLBI NIH HHS HL073907NHLBI NIH HHS P01 HL073907
6 · The paper itself

Abstract

aimsNeutrophils have been found increasingly in the lungs of patients with severe asthma; however, it is unclear whether the neutrophils contribute to the induction of the airway obstruction. We determined using a murine model whether neutrophils are involved in the late asthmatic response (LAR), and analyzed mechanisms underlying the antigen-induced airway neutrophilia. MAIN

methodsBALB/c mice sensitized by ovalbumin (OVA)+Al(OH)(3) were challenged 4 times by intratracheal administration of OVA. Airway mechanics were measured as specific airway resistance. KEY

findingsInduction of the LAR after the 4th challenge coincided with airway neutrophilia. In contrast, eosinophil infiltration was established prior to the 4th challenge. A treatment with an anti-Gr-1 monoclonal antibody (mAb) before the 4th challenge selectively suppressed increases in the neutrophil number and myeloperoxidase (MPO) level in bronchoalveolar lavage fluid (BALF), and attenuated the magnitude of LAR by 60-70%. Selective suppression of eosinophilia by anti-IL-5 mAb had little effect on the LAR. The increases in neutrophil number and MPO level were partially inhibited by an anti-CD4 mAb treatment. The CD4(+) cell depletion also significantly inhibited increases in neutrophil chemoattractants, IL-17A, keratinocyte-derived chemokine (KC) and macrophage inflammatory protein (MIP)-2 in BALF. However, blockade of FcγRII/III failed to suppress the neutrophilia. SIGNIFICANCE: These data suggest that neutrophils are key inducers of the LAR, and that the antigen-induced neutrophilia is partially dependent on activated CD4(+) cells that are involved in the production of IL-17A, KC and MIP-2.

Indexed as

AnimalsAntibodies, MonoclonalAsthmaBronchoalveolar Lavage FluidCD4 Lymphocyte CountCD4-Positive T-LymphocytesDisease Models, AnimalEosinophilsFlow CytometryLeukocyte CountLungMiceMice, Inbred BALB CNeutrophil InfiltrationNeutrophilsOvalbuminAntibodies, MonoclonalGr-1 protein, mouseOvalbuminPeroxidaseReceptors, Chemokine

Identifiers

PMID21565205
PMCPMC3126632
OpenAlexW2052695719

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.